Detoxifying Capacity and Kinetics of the Molecular Adsorbent Recycling System
暂无分享,去创建一个
F. Nevens | B. Maes | B. Bammens | A. Wilmer | D. Kuypers | Y. Vanrenterghem | P. Evenepoel | J. Fevery
[1] J. O’Beirne,et al. Liver support. , 2005, The International journal of artificial organs.
[2] F. Nevens,et al. The Molecular Adsorbent Recirculating System in patients with severe liver failure: clinical results at the K.U. Leuven. , 2002, Liver.
[3] T. Hassanein,et al. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. , 2002, Artificial organs.
[4] V. Sørensen,et al. Hemodynamic changes during a single treatment with the molecular adsorbents recirculating system in patients with acute‐on‐chronic liver failure , 2001, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[5] R. Bartlett,et al. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. , 2001, Surgery.
[6] Ana Ivelisse Avilés,et al. Linear Mixed Models for Longitudinal Data , 2001, Technometrics.
[7] P. Berloco,et al. Use of MARS in the Treatment of Acute Liver Failure: Preliminary Monocentric Experience , 2001 .
[8] P. Sorkine,et al. Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure , 2001, Critical care medicine.
[9] S. Ash. Biocompatibility of sorbent suspension dialysis in cirrhotic patients with hepatic encephalopathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[10] S. Mitzner,et al. Albumin binding capacity (ABiC) is reduced in commercially available human serum albumin preparations with stabilizers. , 2001, Zeitschrift fur Gastroenterologie.
[11] C. Freise,et al. Artificial liver support devices for fulminant liver failure. , 2001, Clinics in liver disease.
[12] R. Cortesini,et al. Use of MARS in the treatment of acute liver failure: preliminar monocentric experience. , 2001, Transplantation proceedings.
[13] S. Mitzner,et al. Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. , 2001, Journal of the American Society of Nephrology : JASN.
[14] K. Böker,et al. Akutes Leberversagen , 2001, Der Internist.
[15] L. Kramer,et al. Biocompatibility of a cuprophane charcoal-based detoxification device in cirrhotic patients with hepatic encephalopathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[16] V. Chadha,et al. Sieving coefficient inaccuracies during hemodiafiltration in patients with hyperbilirubinemia , 2000, Pediatric Nephrology.
[17] M. Löhr,et al. Liver support by extracorporeal blood purification: A clinical observation , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[18] T. Risler,et al. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis mars: Results of a prospective, randomized, controlled clinical trial , 2000, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.
[19] V. Tripodi,et al. Serum bile acids and pruritus in hemodialysis patients. , 2000, Clinical nephrology.
[20] R. Vanholder,et al. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] M. Classen,et al. Albumin dialysis: effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: a new possibility for the elimination of protein-bound toxins. , 1999, Journal of hepatology.
[22] Rahman,et al. Review article: liver support systems in acute hepatic failure , 1999, Alimentary pharmacology & therapeutics.
[23] M. Löhr,et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. , 1999, Artificial organs.
[24] D. Falkenhagen,et al. Fractionated plasma separation and adsorption system: a novel system for blood purification to remove albumin bound substances. , 1999, Artificial organs.
[25] J. Stange,et al. A Carrier-Mediated Transport of Toxins in a Hybrid Membrane. Safety Barrier between a Patients Blood and a Bioartificial Liver , 1996, The International journal of artificial organs.
[26] A. Gimson,et al. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. , 1988, Gastroenterology.
[27] S. Miyake,et al. Bile acids of patients with renal failure receiving chronic hemodialysis , 1986, Steroids.
[28] P. Jatlow,et al. The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. , 1983, The New England journal of medicine.
[29] L. Barbara,et al. Quantitative aspects of the interaction of bile acids with human serum albumin. , 1982, Journal of lipid research.